metricas
covid
Annals of Hepatology Participation of the immune response and oxidative stress in alcoholism and live...
Journal Information
Vol. 30. Issue S1.
Abstracts Asociación Mexicana de Hepatología (AMH) 2024
(April 2025)
Vol. 30. Issue S1.
Abstracts Asociación Mexicana de Hepatología (AMH) 2024
(April 2025)
Full text access
Participation of the immune response and oxidative stress in alcoholism and liver cirrhosis due to alcohol
Visits
417
Leonardo S. Juárez-Chávez1, José L. Pérez-Hernández1, Abigail Hernández-Barragán2, Zaira Medina-Avila2, Marisela Hernandez-Santillan2, Moisés Martínez-Castillo2, Fátima Higuera-De la Tijera1, Gabriela Gutiérrez-Reyes2
1 Gastroenterology Department, General Hospital of México Dr. Eduardo Liceaga, Mexico City, Mexico
2 Liver, Pancreas, and Motility Laboratory (HIPAM), Experimental Medicine Research Unit, Faculty of Medicine, General Hospital of Mexico, Dr. Eduardo Liceaga, Mexico, UNAM, Mexico City, Mexico
This item has received
Article information
Abstract
Full Text
Download PDF
Statistics
Figures (1)
Tables (1)
Table 1. Demographic and biochemical characterization of the study groups.
Tables
Special issue
This article is part of special issue:
Vol. 30. Issue S1

Abstracts Asociación Mexicana de Hepatología (AMH) 2024

More info
Introduction and Objectives

The spectrum of alcoholic liver disease (ALD) includes steatosis, steatohepatitis, alcoholic hepatitis, fibrosis, cirrhosis, and hepatocellular carcinoma. The pathophysiology of liver damage due to chronic alcohol consumption is complex. It is partly a result of reactive oxygen species (ROS) and reactive nitrogen species (RNS), products of oxidative stress, which is one of the mechanisms that will activate the immune system creating a pro-inflammatory state, increasing the levels of several cytokines (TNF-α, IL-1, IL-6, IL-8, MCP-1 and TGF-1).

Objective

To study oxidative stress and the production of proinflammatory cytokines that intervene in the different stages of liver damage due to alcohol (alcoholism, alcohol-related liver cirrhosis, and alcoholic hepatitis).

Material and Patients

A cross-sectional, prospective, and analytical study that included patients from the Gastroenterology service and donors from the Blood Bank. Patients at different stages of the disease and a control group of healthy subjects (blood bank donors) were included. They were divided into 4 groups: Alcoholism (OH), alcoholic liver cirrhosis (CiOH), alcoholic hepatitis (HA), and healthy controls (CT). From each participant, 20 ml of peripheral blood was obtained for the relevant determinations. Normally distributed data were obtained and ANOVA and orthogonal analyses were performed to detect group differences. A U-Mann Whitney test was used. P < 0.05 was taken as a significant difference.

Results

236 subjects were included: 67 patients in OH group; 40 patients with CiOH; 39 patients with Alcoholic Hepatitis (AH), and 90 subjects CT. The gender distribution in patients with ALD (CiOH, and HA) was 77.5% men and 22.5% women. The average alcohol consumption was 376.6±151.6 grams. The CiOH and HA groups presented alterations in platelets, bilirubin, and cytolysis markers at the expense of AST with a significant difference (p<0.05). Regarding oxidative stress, lipoperoxidation was greater in patients with chronic disease (CiOH) and protein damage (protein carbonyls) was greater in HA with p<0.05. Regarding cytokines and chemokines, TNF-α presented a higher level in CiOH and HA (p<0.5), IL-6 presented an elevation in CiOH and HA (p<0.05); IL-10 was elevated in OH, CiOH and HA, MCP-1 and IL-8 showed greater elevation in HA, p<0.05.

Conclusions

Oxidative stress and the elevation of proinflammatory cytokines and chemokines have different behaviors in the various stages of alcohol liver disease, which influences the progression and prognosis of the disease. These findings could be considered as possible therapeutic targets.

Full Text

Ethical statement: Each patient has explained the research in detail. Those who decided to participate signed the informed consent letter.

Declaration of interests: None.

Funding: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Table 1.

Demographic and biochemical characterization of the study groups.

  OH (67)  CiOH (40)  AH (39)  CT (90  P* 
Gener (n) (%)           
Female  21(31)  2(5)  2(5)  28(26)   
Male  46 (69)  38(95)  37(95)  62(74)  b*, c* 
Age  46 ±10  47±8  38±7  38±10  a*, b*, e* 
BMI  27±7  27±7  27±5  28±4   
gr OH/day  320±125  350±130  460±200  1.3±2  a*, b*, c* 
Hb (gr/dL)  14±4  12±3  11.2±0.5  17±1  a*, b*, c* 
Platelets (1000 × 3)  205±95  138±90  93±36  268±65  b*, c* 
BT (mg/dL)  2.3±1.1  3±0.4  18.8±2.4  0.8±0.03  a*, b*, c*, f* 
BD (mg/dL)  1.4±0.5  1.8±0.2  8.6±1.9  0.7±0.03  a*, b*, c* 
AST (U/L)  39±10  63±6  142±17.9  30±1  b*, c*, f* 
ALT (U/L)  31±5  37±3  57.1±5.4  28±2  b*, c*, f* 
GGT (U/L)  70.8±21.9  206±48.8  254±74.8  29.6±2.8  a*, b*, c*, e* 

(OH= Alcoholic, CiOH= alcohol cirrhosis, AH= Alcoholic hepatitis, CT= control). Statistical differences: a. OH vs CT, b. CiOH vs CT, c. HA vs CT, d. OH vs CiOH, e. OH vs HA y f. CiOH vs HA. *p < 0.05

Figure 1. Interleukin IL-8.

(OH= Alcoholic, CiOH= alcohol cirrhosis, HA= Alcoholic hepatitis, CT= control). Statistical differences: a. OH vs CT, b. CiOH vs CT, c. HA vs CT, d. OH vs CiOH, e. OH vs HA y f. CiOH vs HA. *p < 0.05

Download PDF
Article options
Tools